2013
DOI: 10.1101/gad.232710.113
|View full text |Cite
|
Sign up to set email alerts
|

Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation

Abstract: Cancer cells frequently depend on chromatin regulatory activities to maintain a malignant phenotype. Here, we show that leukemia cells require the mammalian SWI/SNF chromatin remodeling complex for their survival and aberrant self-renewal potential. While Brg1, an ATPase subunit of SWI/SNF, is known to suppress tumor formation in several cell types, we found that leukemia cells instead rely on Brg1 to support their oncogenic transcriptional program, which includes Myc as one of its key targets. To account for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

29
392
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 393 publications
(423 citation statements)
references
References 57 publications
29
392
2
Order By: Relevance
“…This region interacts with the MYC promoter in small lymphocytic lymphoma and mantle cell lymphoma, and also leads to MYC transcriptional activation in Epstein-Barr-transformed lymphoblastoid cells as a result of Epstein-Barr virus nuclear antigen 2 binding (52,62). The focal recurrent duplications of this locus observed in CLL (7,53), analogous to what is observed in other malignancies in which CN gains affect the tissue-specific enhancers involved in MYC expression (50,63,64), suggest that the gain of context-specific superenhancers represents a common mechanism for up-regulating MYC expression in distinct tumor types. However, the detection of this superenhancer cluster also in CLL cases devoid of ICN1 expression (Fig.…”
Section: Notch1mentioning
confidence: 62%
“…This region interacts with the MYC promoter in small lymphocytic lymphoma and mantle cell lymphoma, and also leads to MYC transcriptional activation in Epstein-Barr-transformed lymphoblastoid cells as a result of Epstein-Barr virus nuclear antigen 2 binding (52,62). The focal recurrent duplications of this locus observed in CLL (7,53), analogous to what is observed in other malignancies in which CN gains affect the tissue-specific enhancers involved in MYC expression (50,63,64), suggest that the gain of context-specific superenhancers represents a common mechanism for up-regulating MYC expression in distinct tumor types. However, the detection of this superenhancer cluster also in CLL cases devoid of ICN1 expression (Fig.…”
Section: Notch1mentioning
confidence: 62%
“…Super-enhancers are mostly associated with developmentally regulated genes. SMARCA4 is localized at super-enhancers in leukemic and in normal B-cells (Shi et al 2013;Bossen et al 2015). Using the approach previously published , we identified 109 SMARCA4-bound superenhancers in the MCF-10A genome (Fig.…”
Section: Smarca4 Globally Affects Gene Regulation In Mcf-10a Cellsmentioning
confidence: 99%
“…While several studies have noted the association between BRD4 and BRG1 (45), it has not been clear how they might be functionally related in cancer. For example, AML is dependent on both BRD4 (46,47) and BRG1 (43,47) however, their roles in AML transcriptional regulation are very different, making it difficult to determine the functional relevance of this association. We find that the association between BRD4 and BRG1 is specific to GLTSCR1, which will provide a framework for deciphering the functional relevance of this association in both the normal and cancer setting.…”
Section: Proteomic Analysis Of Brg1 Immunoprecipitationsmentioning
confidence: 99%